NCT05922761 BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Status RECRUITING Phase PHASE2
NCT05567406 Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy Status WITHDRAWN Phase PHASE2
NCT04944043 A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04640025 A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib Status TERMINATED Phase PHASE2
NCT04431479 Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04212416 Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03839069 Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis Status UNKNOWN Phase NA
NCT03790332 Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE1/PHASE2
NCT03483675 Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE2
NCT03007238 Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT02959944 Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE3
NCT02749084 Multiple Donor Treg DLI for Severe Refractory Chronic GVHD Status COMPLETED Phase PHASE1/PHASE2
NCT02701634 Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) Status TERMINATED Phase PHASE2
NCT02513498 Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease Status COMPLETED Phase PHASE2
NCT02491359 Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT02461134 Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD Status TERMINATED Phase PHASE2
NCT02352064 Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) Status UNKNOWN Phase NA
NCT02337517 Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease Status TERMINATED Phase PHASE2